BCL2 and medulloblastoma: In medulloblastoma cells, increased expression of the Hh signaling target positively regulated Bcl-2 transcription, whereas pharmacological suppression of Hh activity resulted in decreased Bcl-2 expression and increased apoptosis [6,25].